{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:16:31Z","timestamp":1785107791221,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["#RPG-98-248-01-LBC"],"award-info":[{"award-number":["#RPG-98-248-01-LBC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Thrombotic complications occur in adult patients undergoing stem cell transplantation (SCT), especially following high dose chemo\u2010radiotherapy. There is little published information in children on the impact of SCT on coagulation, as well as potential correlations between altered coagulation and SCT\u2010associated thrombosis and organ failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedure<\/jats:title><jats:p>Forty three pediatric subjects who underwent allogeneic SCT were prospectively evaluated for congenital thrombophilia, anticoagulant levels, coagulation activation, and fibrinolysis at pre\u2010established set points encompassing the period from the 2 to 4 weeks prior to conditioning to 28 days post\u2010transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A significant decrease of protein C and antithrombin levels was found in 39% and 31% of subjects respectively, between SCT days +6 and +7. A peak in plasminogen activator inhibitor\u20101 levels in 31% of subjects was noted between days +9 and +10. No subject experienced a thrombotic event or other SCT\u2010related organ failure. Antithrombin deficiency correlated with underlying malignancy, donor HLA\u2010mismatch, and TBI, whereas decreased PC activity demonstrated a trend of association with lack of T\u2010cell depletion and TBI. Prophylactic heparin did not influence the pattern of acquired hemostatic abnormalities observed in this cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Children undergoing allogeneic SCT develop a state of acquired thrombophilia in the early post\u2010transplantation period. Although no SCT\u2010related thromboembolic events were observed, our results provide new information about the hemostatic changes in children undergoing allogeneic SCT and their potential clinical triggers. The significance of these findings requires further prospective evaluation in a larger cohort of patients. Pediatr Blood Cancer 2008;50:1240\u20131246. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.21473","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T17:47:32Z","timestamp":1202924852000},"page":"1240-1246","source":"Crossref","is-referenced-by-count":16,"title":["A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation"],"prefix":"10.1002","volume":"50","author":[{"given":"Leonardo R.","family":"Brand\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Kletzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Fligman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina P.","family":"Sison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"DiMichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"400","article-title":"Induction of macrophage procoagulant by products of activated lymphocytes","volume":"14","author":"Gezcy CL","year":"1984","journal-title":"Haemostasis"},{"key":"e_1_2_6_3_2","first-page":"416","article-title":"Activation of endothelium\u2010dependent hemostatic factors following bone marrow transplantation","volume":"125","author":"Tsakiris DA","year":"1995","journal-title":"Schweiz Med Wochenschr (Switzerland)"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.1.1"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900801)66:3<515::AID-CNCR2820660319>3.0.CO;2-7"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705215"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.2307\/3578813"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(92)90286-J"},{"key":"e_1_2_6_9_2","first-page":"519","article-title":"Early haemostatic alterations following bone marrow transplantation: A prospective study","volume":"79","author":"Vannucchi AM","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_6_10_2","first-page":"277","article-title":"Endothelium and bone marrow transplantation","volume":"17","author":"Catani L","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996141"},{"key":"e_1_2_6_12_2","first-page":"28","article-title":"Changes in the natural anticoagulants following bone marrow transplantation","volume":"112","author":"Harper PL","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90176-W"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000060011.88230.C8"},{"key":"e_1_2_6_15_2","first-page":"245","article-title":"Hypercoagulability in patients with veno\u2010occlusive disease after bone marrow transplantation","volume":"89","author":"Salat C","year":"1994","journal-title":"Med Klin (Germany)"},{"key":"e_1_2_6_16_2","first-page":"253","article-title":"Hypercoagulability in patients undergoing autologous bone marrow transplantation for hematological malignancies","volume":"12","author":"Catani L","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_17_2","first-page":"56","article-title":"Antithrombin deficiency in special clinical syndromes part II: Hematologic malignancies and bone marrow transplantation","volume":"32","author":"Haire WD","year":"1995","journal-title":"Sem Hematol"},{"key":"e_1_2_6_18_2","first-page":"747","article-title":"Parameters of the fibrinolytic system in patients undergoing BMT: Elevation of PAI\u20101 in veno\u2010occlusive disease","volume":"14","author":"Salat C","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_19_2","first-page":"188","article-title":"Differential radiation response of cultured endothelial cells and smooth myocytes","volume":"4","author":"Johnson LK","year":"1982","journal-title":"Anal Quant Cytol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701445"},{"key":"e_1_2_6_21_2","first-page":"115","article-title":"The fibrinolytic system in newborns and children","volume":"52","author":"Parmar N","year":"2006","journal-title":"Clin Lab"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1642714","article-title":"Developmental hemostasis. Relevance to thromboembolic complications in pediatrics","volume":"74","author":"Andrew M","year":"1995","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_23_2","first-page":"162A","article-title":"Liver toxicity following cytoreductive therapy for marrow transplantation: Risk factors, incidence, and outcome","volume":"14","author":"McDonald GB","year":"1991","journal-title":"Hepatology"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation","volume":"9","author":"Bearman SI","year":"1993","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20626"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on Cyclosporine A prophylaxis who developed acute graft\u2010versus\u2010host disease after HLA identical bone marrow transplantation","volume":"73","author":"Holler E","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200205001-00014"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01223.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/1024533031000084231"},{"key":"e_1_2_6_30_2","first-page":"339","article-title":"Haemolytic uraemic syndrome after bone marrow transplantation: An adverse effect of total body irradiation","volume":"3","author":"Chappell ME","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_31_2","first-page":"211","article-title":"Acquired von Willebrand's disease following bone marrow transplantation","volume":"24","author":"Lazarchick J","year":"1994","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00530.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06126.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200211150-00018"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2001.t01-1-00036.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160507"},{"key":"e_1_2_6_37_2","first-page":"201","article-title":"Pulmonary thromboembolism in leukemic children undergoing bone marrow transplantation","volume":"11","author":"Uderzo C","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi111"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111272"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-01-0033"},{"key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642556","article-title":"Plasminogen activator inhibitor\u20101 and plasminogen activator inhibitor\u20102 in various disease states","volume":"59","author":"Kruithof EK","year":"1988","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"17128","DOI":"10.1016\/S0021-9258(18)41903-5","article-title":"Plasminogen activator inhibitor\u20101 binds to fibrin and inhibits tissue\u2010type plasminogen activator\u2010mediated fibrin dissolution","volume":"267","author":"Reilly CF","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0037-1614564","article-title":"The relationship of mutations in the MTHFR, prothrombin, and PAI\u20101 genes to plasma levels of homocysteine, prothrombin, and PAI\u20101 in children and adults","volume":"81","author":"Balasa VV","year":"1998","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.2.139"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000220378.06854.35"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8473"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00007"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21473","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21473","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:37:18Z","timestamp":1697629038000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1002\/pbc.21473"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21473","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}